HomeCompareMAYNF vs EQR

MAYNF vs EQR: Dividend Comparison 2026

MAYNF yields 121.95% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAYNF wins by $9.15M in total portfolio value
10 years
MAYNF
MAYNF
● Live price
121.95%
Share price
$1.64
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.20M
Annual income
$3,519,740.94
Full MAYNF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — MAYNF vs EQR

📍 MAYNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMAYNFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MAYNF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MAYNF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MAYNF
Annual income on $10K today (after 15% tax)
$10,365.85/yr
After 10yr DRIP, annual income (after tax)
$2,991,779.80/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, MAYNF beats the other by $2,987,125.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MAYNF + EQR for your $10,000?

MAYNF: 50%EQR: 50%
100% EQR50/50100% MAYNF
Portfolio after 10yr
$4.62M
Annual income
$1,762,608.27/yr
Blended yield
38.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

MAYNF
No analyst data
Altman Z
-0.6
Piotroski
5/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MAYNF buys
0
EQR buys
0
No recent congressional trades found for MAYNF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMAYNFEQR
Forward yield121.95%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$9.20M$47.8K
Annual income after 10y$3,519,740.94$5,475.61
Total dividends collected$8.37M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MAYNF vs EQR ($10,000, DRIP)

YearMAYNF PortfolioMAYNF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$22,895$12,195.12$11,380$679.82+$11.5KMAYNF
2$50,592$26,094.28$13,014$837.25+$37.6KMAYNF
3$108,023$53,889.10$14,961$1,036.20+$93.1KMAYNF
4$223,119$107,534.91$17,297$1,289.22+$205.8KMAYNF
5$446,319$207,581.09$20,121$1,613.15+$426.2KMAYNF
6$865,633$388,071.89$23,561$2,030.84+$842.1KMAYNF
7$1,629,651$703,423.94$27,783$2,573.54+$1.60MMAYNF
8$2,981,366$1,237,639.89$33,013$3,284.39+$2.95MMAYNF
9$5,306,138$2,116,076.08$39,547$4,223.51+$5.27MMAYNF
10$9,197,309$3,519,740.94$47,791$5,475.61+$9.15MMAYNF

MAYNF vs EQR: Complete Analysis 2026

MAYNFStock

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Full MAYNF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this MAYNF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MAYNF vs SCHDMAYNF vs JEPIMAYNF vs OMAYNF vs KOMAYNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.